LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | JW-7-24-1 | 0.12 | uM | LJP6 | 1 | B23 | 72 | hr | 1401 | 3459 | 4223 | 0.8191 | 0.7292 |
| SK-BR-3 | JW-7-24-1 | 0.12 | uM | LJP6 | 2 | B23 | 72 | hr | 1401 | 3390 | 4223 | 0.8027 | 0.7047 |
| SK-BR-3 | JW-7-24-1 | 0.12 | uM | LJP6 | 3 | B23 | 72 | hr | 1401 | 3219 | 4223 | 0.7622 | 0.6441 |
| SK-BR-3 | Lapatinib | 0.12 | uM | LJP6 | 1 | M23 | 72 | hr | 1401 | 1401 | 4223 | 0.3318 | -0.0002 |
| SK-BR-3 | Lapatinib | 0.12 | uM | LJP6 | 2 | M23 | 72 | hr | 1401 | 1545 | 4223 | 0.3659 | 0.0508 |
| SK-BR-3 | Lapatinib | 0.12 | uM | LJP6 | 3 | M23 | 72 | hr | 1401 | 1553 | 4223 | 0.3677 | 0.0537 |
| SK-BR-3 | LDN-193189 | 0.12 | uM | LJP5 | 1 | G05 | 72 | hr | 1401 | 3356 | 4223 | 0.7947 | 0.6927 |
| SK-BR-3 | LDN-193189 | 0.12 | uM | LJP5 | 2 | G05 | 72 | hr | 1401 | 4240 | 4223 | 1.0040 | 1.0060 |
| SK-BR-3 | LDN-193189 | 0.12 | uM | LJP5 | 3 | G05 | 72 | hr | 1401 | 4648 | 4223 | 1.1006 | 1.1506 |
| SK-BR-3 | Linifanib | 0.12 | uM | LJP6 | 1 | J11 | 72 | hr | 1401 | 4527 | 4223 | 1.0720 | 1.1077 |
| SK-BR-3 | Linifanib | 0.12 | uM | LJP6 | 2 | J11 | 72 | hr | 1401 | 4117 | 4223 | 0.9749 | 0.9624 |
| SK-BR-3 | Linifanib | 0.12 | uM | LJP6 | 3 | J11 | 72 | hr | 1401 | 4795 | 4223 | 1.1354 | 1.2027 |
| SK-BR-3 | Linsitinib | 0.12 | uM | LJP5 | 1 | O23 | 72 | hr | 1401 | 3418 | 4223 | 0.8094 | 0.7147 |
| SK-BR-3 | Linsitinib | 0.12 | uM | LJP5 | 2 | O23 | 72 | hr | 1401 | 3944 | 4223 | 0.9339 | 0.9011 |
| SK-BR-3 | Linsitinib | 0.12 | uM | LJP5 | 3 | O23 | 72 | hr | 1401 | 4254 | 4223 | 1.0073 | 1.0110 |
| SK-BR-3 | Mitoxantrone | 0.12 | uM | LJP5 | 1 | C23 | 72 | hr | 1401 | 1582 | 4223 | 0.3746 | 0.0640 |
| SK-BR-3 | Mitoxantrone | 0.12 | uM | LJP5 | 2 | C23 | 72 | hr | 1401 | 1558 | 4223 | 0.3689 | 0.0555 |
| SK-BR-3 | Mitoxantrone | 0.12 | uM | LJP5 | 3 | C23 | 72 | hr | 1401 | 1404 | 4223 | 0.3325 | 0.0009 |
| SK-BR-3 | Mitoxantrone | 0.12 | uM | LJP6 | 1 | C23 | 72 | hr | 1401 | 1510 | 4223 | 0.3576 | 0.0384 |
| SK-BR-3 | Mitoxantrone | 0.12 | uM | LJP6 | 2 | C23 | 72 | hr | 1401 | 1439 | 4223 | 0.3408 | 0.0133 |
| SK-BR-3 | Mitoxantrone | 0.12 | uM | LJP6 | 3 | C23 | 72 | hr | 1401 | 1355 | 4223 | 0.3209 | -0.0165 |
| SK-BR-3 | MK2206 | 0.12 | uM | LJP6 | 1 | F05 | 72 | hr | 1401 | 2771 | 4223 | 0.6562 | 0.4854 |
| SK-BR-3 | MK2206 | 0.12 | uM | LJP6 | 2 | F05 | 72 | hr | 1401 | 2767 | 4223 | 0.6552 | 0.4839 |
| SK-BR-3 | MK2206 | 0.12 | uM | LJP6 | 3 | F05 | 72 | hr | 1401 | 2923 | 4223 | 0.6922 | 0.5392 |
| SK-BR-3 | Neratinib | 0.12 | uM | LJP5 | 1 | A17 | 72 | hr | 1401 | 1416 | 4223 | 0.3353 | 0.0051 |